(Q30428895)

21 June 2017

title

Diabetes-associated macrovascular complications: cell-based therapy a new tool? (English)

1 reference

21 June 2017

Maddalena Gili

1

1 reference

21 June 2017

Alberto Orsello

series ordinal

2

1 reference

21 June 2017

Sara Gallo

series ordinal

3

1 reference

21 June 2017

Maria Felice Brizzi

series ordinal

4

1 reference

21 June 2017

publication date

30 March 2013

1 reference

21 June 2017

1 reference

21 June 2017

volume

44

1 reference

21 June 2017

issue

3

1 reference

21 June 2017

page(s)

557-575

1 reference

Clinical practice. Glycemic management of type 2 diabetes mellitus

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

The burden of diabetes and its complications: trends and implications for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Prevention and early detection of vascular complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Remodeling of blood vessels: responses of diameter and wall thickness to hemodynamic and metabolic stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Small artery structure in hypertension. Dual processes of remodeling and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Abnormal angiogenesis in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Arteriogenesis versus angiogenesis: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Signal transduction in vasculogenesis and developmental angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Mesenchymal stem cell therapy for heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Synergistic effect of sustained delivery of basic fibroblast growth factor and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Paracrine mechanisms in adult stem cell signaling and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Nuclear receptor regulation of stemness and stem cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Mesenchymal stromal cells: new directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Advances in cell-based therapy for peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Regenerating new heart with stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Autologous bone marrow mononucleated cell preparation for the clinical treatment of acute myocardial infarction and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Intravenous autologous bone marrow mononuclear cells for ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Stem cell treatment for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Biology of bone marrow-derived endothelial cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Cell therapies for therapeutic angiogenesis: back to the bench

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Stem cells in cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Mobilization of stem and progenitor cells in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

From bench to bedside: what physicians need to know about endothelial progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Mobilization of endothelial progenitor cells in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Alloimmunity to human endothelial cells derived from cord blood progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

21 January 2018

In search of "stemness".

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Mesenchymal precursor cells in the blood of normal individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Umbilical cord blood stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Pluripotency of mesenchymal stem cells derived from adult marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Mesenchymal stem cells and their potential as cardiac therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Adipose-derived stem cells: isolation, expansion and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Autologous adipose tissue as a new source of progenitor cells for therapeutic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

The tumorigenicity of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Development of pluripotent stem cells for vascular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Generation of mouse induced pluripotent stem cells without viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Induced pluripotent stem cells: the new patient?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Endothelial progenitor cells and vascular biology in diabetes mellitus: current knowledge and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Unacylated ghrelin rescues endothelial progenitor cell function in individuals with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Diabetes impairs arteriogenesis in the peripheral circulation: review of molecular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Role of oxidative stress in development of complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Type 2 diabetes restricts multipotency of mesenchymal stem cells and impairs their capacity to augment postischemic neovascularization in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Diabetes increases mortality after myocardial infarction by oxidizing CaMKII

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Stem cell therapy in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Stem cells for cardiac repair: status, mechanisms, and new strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Age, gender and diabetic status are associated with effects of bone marrow cell therapy on recovery of left ventricular function after acute myocardial infarction: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Aging, progenitor cell exhaustion, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Endothelial progenitor cells in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Transfusion of CXCR4-primed endothelial progenitor cells reduces cerebral ischemic damage and promotes repair in db/db diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Peripheral arterial disease--what do we need to know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Management of dyslipidemia in children and adolescents with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Peripheral arterial disease in diabetes--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Comprehensive medical management of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Gene transfer as a tool to induce therapeutic vascular growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Adenovirus-mediated ex vivo gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscle oxygen tension and induces arteriogenesis in ischemic rat hindlimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Dual gene transfer of fibroblast growth factor-2 and platelet derived growth factor-BB using plasmid deoxyribonucleic acid promotes effective angiogenesis and arteriogenesis in a rodent model of hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Regenerative medicine in the treatment of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Adipose stromal cells amplify angiogenic signaling via the VEGF/mTOR/Akt pathway in a murine hindlimb ischemia model: a 3D multimodality imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Intravenous thrombolytic therapy for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Race/ethnicity, quality of care, and outcomes in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Guidelines for the Early Management of Adults With Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Comparison of outcomes following thrombolytic therapy among patients with prior stroke and diabetes in the Virtual International Stroke Trials Archive (VISTA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Treatment of neural injury with marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Circulating CD34-positive cells provide an index of cerebrovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Formation of STAT5/PPARgamma transcriptional complex modulates angiogenic cell bioavailability in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Socializing with the neighbors: stem cells and their niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Extracellular matrix, integrins, and growth factors as tailors of the stem cell niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Regenerative therapies for diabetic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Stem cells in the diabetic infarcted heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

21 January 2018

12 December 2020

Isolation of multipotent adult stem cells from the dermis of mammalian skin

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Nonbone Marrow-Derived Circulating Progenitor Cells Contribute to Postnatal Neovascularization Following Tissue Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9936-8

Cellular mechanisms of arteriogenesis.

21 January 2018

1 reference

12 December 2020

Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia

1 reference

12 December 2020

Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.

1 reference

12 December 2020

Increase of palmitic acid concentration impairs endothelial progenitor cell and bone marrow-derived progenitor cell bioavailability: role of the STAT5/PPARγ transcriptional complex.

1 reference

12 December 2020

Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia

1 reference

12 December 2020

The range of adaptation by collateral vessels after femoral artery occlusion

1 reference

12 December 2020

Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use

1 reference

12 December 2020

Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction

1 reference

12 December 2020

Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes

1 reference

12 December 2020

Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium

1 reference

12 December 2020

Effects of the different culture and isolation methods on the growth, proliferation and biology characteristics of rat bone marrow mesenchymal stem cells

1 reference

12 December 2020

Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood

1 reference

12 December 2020

Intramyocardial, autologous CD34+ cell therapy for refractory angina

1 reference

12 December 2020

Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

1 reference

12 December 2020

Intra-Arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Patients with Moderate to Severe Middle Cerebral Artery Acute Ischemic Stroke

1 reference

12 December 2020

Acute stroke therapy at the crossroads

1 reference

12 December 2020

Characterization of macro-and microvascular function and structure in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion

1 reference

12 December 2020

Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury

1 reference

12 December 2020

1 reference

12 December 2020

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

1 reference

12 December 2020

Diabetes impairs mobilization of stem cells for the treatment of cardiovascular disease: a meta-regression analysis.

1 reference

12 December 2020

Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures

1 reference

12 December 2020

Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity

1 reference

12 December 2020

Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke

1 reference

12 December 2020

Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs

1 reference

12 December 2020

Restoring stem cell mobilization to promote vascular repair in diabetes.

1 reference

12 December 2020

Autologous mononuclear bone marrow cells during reparative regeneratrion after acute myocardial infarction

1 reference

12 December 2020

Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials

1 reference

12 December 2020

p53 Mediates the accelerated onset of senescence of endothelial progenitor cells in diabetes

1 reference

12 December 2020

Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor

1 reference

12 December 2020

Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy

1 reference

12 December 2020

Peripheral arterial disease in people with diabetes

1 reference

12 December 2020

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

12 December 2020

Autologous transplantation of bone marrow cells improves damaged heart function

1 reference

12 December 2020

Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial

1 reference

12 December 2020

[Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction]

1 reference

12 December 2020

Bone Marrow-Derived Progenitor Cells in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy

1 reference

12 December 2020

The Increase of Circulating Endothelial Progenitor Cells After Acute Ischemic Stroke Is Associated With Good Outcome

1 reference

12 December 2020

A diabetic milieu promotes OCT4 and NANOG production in human visceral-derived adipose stem cells

1 reference

12 December 2020

VEGF administration in chronic myocardial ischemia in pigs

1 reference

12 December 2020

The heterogeneity of human mesenchymal stem cell preparations--evidence from simultaneous analysis of proteomes and transcriptomes

1 reference

12 December 2020

Basic fibroblast growth factor enhances myocardial collateral flow in a canine model

1 reference

12 December 2020

Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement

1 reference

12 December 2020

Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of

1 reference

12 December 2020

Diabetes mellitus: diagnosis and screening.

1 reference

12 December 2020

Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury

1 reference

12 December 2020

Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs

1 reference

12 December 2020

Effect of bone marrow-derived mesenchymal stem cells on cardiovascular complications in diabetic rats.

1 reference

12 December 2020

Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging.

1 reference

12 December 2020

Cell-enhancement strategies for the treatment of ischemic heart disease

1 reference

12 December 2020

Autologous mesenchymal stem cell transplantation in stroke patients

1 reference

12 December 2020

1 reference

12 December 2020

Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction

1 reference

12 December 2020

Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation

1 reference

12 December 2020

Long-term effects of repeated autologous transplantation of bone marrow cells in patients affected by peripheral arterial disease

1 reference

12 December 2020

Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals

1 reference

12 December 2020

10.1007/S12020-013-9936-8

Identifiers

DOI

1 reference

21 June 2017

1 reference